About Indisuan Pharmaceuticals Private Limited
Data last updated:
Indisuan Pharmaceuticals Private Limited is a foreign private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Suan Farma, S.A.. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2018FTC307297. Its GSTIN is 27AAECI8210R1Z3 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Jawed Zia and Amol Pramod Salvi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 709 A Wing Shelton Sapphire Sector No 15 CBD Belapur, Navi Mumbai, Maharashtra, India – 400614.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.12 Cr, a decline of 55% compared to the previous year. For the same year it recorded a net profit of ₹66.08 Lakh (net margin 2.1%) and EBITDA of ₹2.34 Cr (EBITDA margin 7.5%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Suanfarma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suanfarma.com.
Company details
Contact details
Indisuan Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is suanfarma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address709 A Wing Shelton Sapphire Sector No 15 CBD Belapur, Navi Mumbai, Maharashtra, India – 400614
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Indisuan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Indisuan Pharmaceuticals operates one associated brand: Suanfarma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generics, nutraceuticals, and APIs are developed by Suanfarma. | suanfarma.com |
Business activity
The main business activity of Indisuan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Indisuan Pharmaceuticals Private Limited, buy the company report.
Financials of Indisuan Pharmaceuticals Private Limited
FY 2024 filings availableIndisuan Pharmaceuticals Private Limited reported revenue of ₹31.12 Cr (down 55% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 55% fall in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.34 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indisuan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indisuan Pharmaceuticals Private Limited
Indisuan Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jawed Zia Also directs: Nilocas India Private Limited, Acture Health Private Limited | Additional Director | 31 Jan 2025 | 1 Years 8 Months | Current |
| Amol Pramod Salvi | Additional Director | 07 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Indisuan Pharmaceuticals Private Limited is audited by MNRD & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MNRD & Associates | FY 2022 | 126991W |
Shareholding
The shareholding of Indisuan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Indisuan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indisuan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indisuan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Indisuan Pharmaceuticals Private Limited has a workforce of 7 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Indisuan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECI8210R1Z3 | Maharashtra | Active | 16 May 2018 |
To see the full GST registrations and return filing status of Indisuan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indisuan Pharmaceuticals Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Harsh Vardhan Laxminarayan Pandey ceased to be Director on 15 Apr 2025.
News
Frequently asked questions
Indisuan Pharmaceuticals is an active foreign private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2018 (8+ years old) and is registered under CIN U51909MH2018FTC307297.
Indisuan Pharmaceuticals has 2 current directors:
- Jawed Zia - Additional Director
- Amol Pramod Salvi - Additional Director
The latest financial statements of Indisuan Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Indisuan Pharmaceuticals is 27AAECI8210R1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indisuan Pharmaceuticals is U51909MH2018FTC307297. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indisuan Pharmaceuticals was incorporated on 28 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Harsh Vardhan Laxminarayan Pandey ceased to be Director on 15 Apr 2025. Amol Pramod Salvi was appointed as Additional Director on 07 Apr 2025. Francisco Jose Fernandez Saniger ceased to be Director on 03 Feb 2025. Indisuan Pharmaceuticals has 5 board changes on record in total.
Indisuan Pharmaceuticals can be reached through the website suanfarma.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Indisuan Pharmaceuticals is at 709 A Wing Shelton Sapphire Sector No 15 CBD Belapur, Navi Mumbai, Maharashtra, India – 400614.
Indisuan Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
